NCT02099851View on ClinicalTrials.gov

Endovascular Carotid Body Ablation in Patients With Treatment- Resistant Hypertension: A Safety and Feasibility Study

NAUnknownINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

December 31, 2016

Conditions
Hypertension
Interventions
DEVICE

Carotid body ablation (Cibiem)

Trial Locations (2)

150 30

Na Homolce Hospital, Roentgenova 2, Prague

80-952

Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk

Sponsors

Lead Sponsor

Noblewell
All Listed Sponsors
lead

Noblewell

INDUSTRY

NCT02099851 - Endovascular Carotid Body Ablation in Patients With Treatment- Resistant Hypertension: A Safety and Feasibility Study | Biotech Hunter | Biotech Hunter